Wave Life Sciences WVE Operating Income
Operating Income at other companies
Other financials
Where this comes from
Reported directly by Wave Life Sciences in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The official record: Wave Life Sciences’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →
Ask your AI about Wave Life Sciences's operating income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Wave Life Sciences's operating income?
- Wave Life Sciences (WVE) reported operating income of -$31.3M in Q1 2026.
- How has Wave Life Sciences's operating income changed year-over-year?
- Wave Life Sciences's operating income increased by 37.2% year-over-year, from -$49.8M to -$31.3M.
- What is the long-term trend for Wave Life Sciences's operating income?
- Over 3 years (2021 to 2025), Wave Life Sciences's operating income has grown at a 19.2% compound annual growth rate (CAGR), from -$127.02M to -$215.38M.
- What does operating income mean?
- Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.